1. Mewara A, Sreenivasan P, Khurana S. Primate malaria of human importance. Trop Parasitol. 2023;13(2):73-83.
2. Chaturvedi R, Biswas S, Bisht K, Sharma A. The threat of increased transmission of non-knowlesi zoonotic malaria in humans: a systematic review. Parasitology. 2023; 150(13): 1167–1177.
3. Moxon CA, Gibbins MP, McGuinness D, Milner DA Jr, Marti M. New Insights into Malaria Pathogenesis. Annu Rev Pathol. 2020; 15: 315-343.
4. Sato S. Plasmodium-a brief introduction to the parasites causing human malaria and their basic biology. J Physiol Anthropol. 2021; 40(1): 1.
5. Calderaro A, Piccolo G, Chezzi C. The Laboratory Diagnosis of Malaria: A Focus on the Diagnostic Assays in Non-Endemic Areas. Int J Mol Sci. 2024; 25(2): 695.
6. Venugopal K, Hentzschel F, Valkiūnas G, et al. Plasmodium asexual growth and sexual development in the haematopoietic niche of the host. Nat Rev Microbiol. 2020; 18: 177–189.
7. Boualam MA, Pradines B, Drancourt M, Barbieri R. Malaria in Europe: A Historical Perspective. Front Med. 2021; 8: 691095.
8. Carlton JM. Publisher Correction: Evolution of human malaria. Nat Microbiol. 2018; 3(10): 1188.
9. Petithory JC. On the discovery of the parasite of malaria by A. Laveran: Bône 1878 – Constantine 1880. Hist Sci Med. 1995; 29(1): 57-62.
10. Majori G. Short history of malaria and its eradication in Italy with short notes on the fight against the infection in the mediterranean basin. Mediterr J Hematol Infect Dis. 2012; 4(1): e2012016.
11. World Health Organization (WHO). World malaria report 2023. Erişim linki: https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2023 (Erişim tarihi: 26
Temmuz 2024)
12. Özcel MA. Sıtma. In: Özcel MA, Özbel Y, Ak M eds. Özcel’in Tıbbi Parazit Hastalıkları. 1.baskı. İzmir; 2007.
13. Tuğluoğlu F. Türkiye’de Sıtma Mücadelesi (1924-1950). Turkiye Parazitol Derg. 2008; 32 (4): 351 – 359.
14. Centers for Disease Control and Prevention (CDC). DPDx – Laboratory Identification of Parasites of Public Health Concern. Erişim linki: https://www.cdc.gov/dpdx/malaria/index.html
(Erişim tarihi: 26 Temmuz 2024)
15. Garcia LS. Malaria. Clin Lab Med. 2010; 30(1): 93-129.
16. Erişim linki: https://www.parasite.org.au/para-site/text/plasmodium-text.html (Erişim tarihi: 26 Temmuz 2024)
17. Oaks SC Jr, Mitchell VS, Pearson GW, Carpenter CCJ. Malaria: Obstacles and Opportunities. In: Committee for the Study on Malaria Prevention and Control eds. Parasite Biology. Division
of International Health Washington (DC): National Academies Press (US); 1991. 6, https://www.ncbi.nlm.nih.gov/books/NBK234327/
18. Real E, Mancio SL. Single-cell views of the Plasmodium life cycle. Trends Parasitol. 2022; 38(9): 748-757.
19. Quaye IK, Aleksenko L, Paganotti GM, et al. Malaria Elimination in Africa: Rethinking Strategies for Plasmodium vivax and Lessons from Botswana. Trop Med Infect Dis. 2023; 8: 392.
20. El-Moamly AA, El-Sweify MA. Malaria vaccines: the 60-year journey of hope and final success-lessons learned and future prospects. Trop Med Health. 2023; 51(1): 29.
21. Poespoprodjo JR, Douglas NM, Ansong D, Kho S, Anstey NM. Malaria. Lancet. 2023; 402(10419): 2328-2345.
22. Cowman AF, Healer J, Marapana D, Marsh K. Malaria: Biology and Disease. Cell. 2016; 167(3): 610-624.
23. Meibalan E, Marti M. Biology of Malaria Transmission. Cold Spring Harb Perspect Med. 2017; 7: a025452.
24. Rossati A, Bargiacchi O, Kroumova V, Zaramella M, Caputo A, Garavelli PL. Climate, environment and transmission of malaria. Infez Med. 2016; 24(2): 93-104.
25. Phillips MA, Burrows JN, Manyando C, van Huijsduijnen RH, Van Voorhis WC, Wells TNC. Malaria. Nat Rev Dis Primers. 2017; 3: 17050.
26. González Sanz M, Berzosa P, Norman FF. Updates on Malaria Epidemiology and Prevention Strategies. Curr Infect Dis Rep. 2023; 8: 1-9.
27. Randall MP. The Makıng of A Tropıcal Dısease A Short History of Malaria. In: Randall MP ed. Second edition. The Johns Hopkins University Press Baltimore, Maryland, 2011.
28. Daily JP, Minuti A, Khan N. Diagnosis, Treatment, and Prevention of Malaria in the US: A Review. JAMA. 2022; 328(5): 460-471.
29. Marchand RP, Culleton R, Maeno Y, Quang NT, Nakazawa S. Co-infections of Plasmodium knowlesi, P. falciparum, and P. vivax among Humans and Anopheles dirus Mosquitoes, Southern
Vietnam. Emerg Infect Dis. 2011; 17(7): 1232-9.
30. Ta TH, Hisam S, Lanza M, Jiram AI, Ismail N, Rubio JM. First case of a naturally acquired human infection with Plasmodium cynomolgi. Malar J. 2014; 13: 68.
31. Song X, Wei W, Cheng W, et al. Cerebral malaria induced by plasmodium falciparum: clinical features, pathogenesis, diagnosis, and treatment. Front Cell Infect Microbiol. 2022; 12: 939532.
32. Milner DA Jr. Malaria Pathogenesis. Cold Spring Harb Perspect Med. 2018; 8(1): a025569.
33. Ashley EA, Pyae Phyo A, Woodrow CJ. Malaria. Lancet. 2018; 391(10130): 1608-1621.
34. Higgins M, Manko E, Ward D, et al. New reference genomes to distinguish the sympatric malaria parasites, Plasmodium ovale curtisi and Plasmodium ovale wallikeri. Sci Rep. 2024; 14(1):
3843.
35. O’Flaherty K, Roe M, Fowkes FJI. The role of naturally acquired antimalarial antibodies in subclinical Plasmodium spp. infection. J Leukoc Biol. 2022; 111(5): 1097-1105.
36. Yildiz Zeyrek F, Kurcer MA, Zeyrek D, Simsek Z. Parasite density and cytokine levels in Plasmodium vivax malaria in Turkey. Parasite Immunology. 2006; 28: 201-207.
37. Yildiz Zeyrek F, Babaoglu A, Demirel S, et al. Analysis of Naturally Acquired Antibody Responses to 19-Kda C-Terminal Region of The Merozoite Surface Protein-1 of Plasmodium vivax From
İndividuals İn Sanliurfa, Turkey. Am J Trop Med Hyg. 2008; 78(5): 729-32.
38. Yildiz Zeyrek F, Palacpac N, Yuksel F, et al. Serologic markers in relation to parasite exposure history help to estimate transmission dynamics of Plasmodium vivax. PLoS ONE. 2011; 6 (11):
e28126.
39. Yıldız Zeyrek F. Malaria. İn: Korkmaz M, Ok ÜZ, eds. Parazitolojide Laboratuvar. Yayın No:23. İzmir; 2011.
40. Kojom Foko LP, Singh V. Malaria in pregnancy in India: a 50-year bird’s eye. Front Public Health. 2023; 11: 1150466.
41. Sahu PK, Mohanty S. Pathogenesis of Cerebral Malaria: New Trends and Insights for Developing Adjunctive Therapies. Pathogens. 2023; 12: 522.
42. World Health Organization (WHO). Global technıcal strategy for malarıa 2016–2030, 2021 update. Erişim linki: https://www.who.int/publications/i/item/9789240031357 (Erişim tarihi: 26
Temmuz 2024)
43. Varo R, Balanza N, Mayor A, Bassat Q. Diagnosis of clinical malaria in endemic settings. Expert Review of Anti-Infective Therapy. 2020; 19(1): 79–92.
44. Centers for Disease Control and Prevention (CDC). Evaluation and Diagnosis. Erişim linki: https://www.cdc.gov/malaria/hcp/clinical-guidance/evaluation-diagnosis.html (Erişim tarihi: 26
Temmuz 2024)
45. Huber JH, Elliott M, Koepfli C, Perkins TA. The Impact of Emerging Plasmodium knowlesi on Accurate Diagnosis by Light Microscopy: A Systematic Review and Modeling Analysis. Am J
Trop Med Hyg. 2023; 108(1): 61–68.
46. Kavanaugh MJ, Azzam SE, Rockabrand DM. Malaria Rapid Diagnostic Tests: Literary Review and Recommendation for a Quality Assurance, Quality Control Algorithm. Diagnostics. 2021;
11: 768.
47. Das S, Peck RB, Barney R. Performance of an ultra-sensitive Plasmodium falciparum HRP2-based rapid diagnostic test with recombinant HRP2, culture parasites, and archived whole blood
samples. Malar J. 2018; 17(1): 118.
48. WHO. Global Malaria Programme. Rapid Diagnostic Tests. Erişim linki: https://www.who.int/teams/global-malaria-programme/casemanagement/diagnosis/rapid-diagnostic-tests (Erişim
tarihi: 26 Temmuz 2024)
49. Snounou G, Viriyakosol S, Zhu XP, et al. High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction. Mol Biochem Parasitol. 1993; 61: 315–320.
50. Gadalla AAH, Siciliano G, Farid R, et al. Real-time PZR assays for detection and quantification of early P. falciparum gametocyte stages. Sci Rep. 2021; 27: 19118.
51. Roth JM, Korevaar DA, Leeflang MM, et al. Molecular malaria diagnostics: A systematic review and meta-analysis. Crit Rev Clin Lab Sci. 2016; 53(2): 87-105.
52. Smits HL, Gussenhoven GC, Terpstra W, et al. Detection, identification and semi-quantification of malaria parasites by NASBA amplification of small subunit ribosomal RNA sequences. J
Microbiol Methods. 1997; 28(1): 65-75.
53. Schneider P, Wolters L, Schoone G, et al. Real-time nucleic acid sequence-based amplification is more convenient than real-time PZR for quantification of Plasmodium falciparum. J Clin
Microbiol. 2005; 43(1): 402-5.
54. Mens P, Spieker N, Omar S, et al. Is molecular biology the best alternative for diagnosis of malaria to microscopy? A comparison between microscopy, antigen detection and molecular tests
in rural Kenya and urban Tanzania. Trop Med Int Health. 2007; 12(2): 238-44.
55. Stauning MA, Jensen CS, Staalse T, Kurtzhals JAL. Detection and quantification of Plasmodium falciparum in human blood by matrix-assisted laser desorption/ionization time-of-flight mass
spectrometry: A proof of concept study. Malar J. 2023; 26: 285.
56. Centers for Disease Control and Prevention (CDC). General Approach to Treatment. Erişim linki: https://www.cdc.gov/malaria/hcp/clinical-guidance/general-treatment.html (Erişim tarihi:
26 Temmuz 2024)